Basic information |
Metabolite name | N-Acetylaspartylglutamic acid |
HMDB0001067 | |
C12270 | |
5255 | |
Synonyms | 2-[(2-Acetamido-3-carboxy-1-oxopropyl)amino]pentanedioic acid; |
No. of studies | 7 |
Relationship between N-Acetylaspartylglutamic acid and depression (count: 7) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M1005 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
Study M1005 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M1005 | Type1 | CUMS group vs. control group | Ileum | Sprague-Dawley rat | Down |
Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Ileum | Sprague-Dawley rat | Up |
Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Ileum | Sprague-Dawley rat | Up |
Study M1090 | Type3 | hyperbaric oxygen treatment group vs. control group | Plasma | BALb/c mouse | Up |
Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Up |
Study M578 | Type1 | restraint stress offspring group vs. control offspring group | Hippocampus | Sprague-Dawley rat | Up |
Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
Study M849 | Type1 | CUMS group vs. control group | Brain | C57BL/6 mouse | Up |